Epidemiology of Cutaneous Leishmaniasis in a Colombian Municipality
- 8 November 2017
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 97 (5) , 1503-1507
Abstract
This study describes the epidemiological and clinical characteristics of leishmaniasis and the pharmacological treatment of this disease in the municipality of Pueblo Rico, Risaralda, between January 2010 and December 2014. An observational study was conducted using information from the clinical records and epidemiological reports of patients diagnosed and confirmed with leishmaniasis of any age and sex, including sociodemographic, clinical, and pharmacological variables of the therapy received. Univariate and bivariate analyses were performed. A total of 539 cases of leishmaniasis were confirmed, with 29.5% occurring in children under 5 years of age. The median age was 10 years, with predominance in males (55.5%). The indigenous Emberá (aboriginal Americans) were the most affected (50.8%), and 93.3% of cases occurred in people living in scattered rural areas. All lesions corresponded to cutaneous leishmaniasis, of which 251 patients had compromise of the upper limbs (46.6%), 221 of the face (41.0%), and 139 of the lower limbs (25.8%). Pentavalent antimony salts (n-methyl glucamine and sodium stibogluconate) were prescribed in 77.6% (N = 418) of the cases; miltefosine was the second most frequently prescribed medication (21.5%, N = 116). The inhabitants of rural areas and the indigenous communities are at a higher risk of acquiring the infection, particularly among infants, which highlights the importance of the biological, social, and demographic factors involved in the disease. There is a need to seek effective public health actions and further research this disease.Keywords
This publication has 18 references indexed in Scilit:
- Study of the scientific production on leishmaniasis in Latin America.Recent Patents on Anti-Infective Drug Discovery, 2015
- An update on pharmacotherapy for leishmaniasisExpert Opinion on Pharmacotherapy, 2014
- Assessing epidemiology of cutaneous leishmaniasis in Isfahan, IranJournal of Vector Borne Diseases, 2013
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- LeishmaniasisHuman Vaccines, 2011
- Cutaneous leishmaniasisThe Lancet Infectious Diseases, 2007
- Pharmacokinetics of Antimony in Children Treated for Leishmaniasis with Meglumine AntimoniateThe Journal of Infectious Diseases, 2007
- LeishmaniasisPostgraduate Medical Journal, 2007
- The epidemiology and control of leishmaniasis in Andean countriesCadernos de Saude Publica, 2000
- Distribution and Etiology of Leishmaniasis in ColombiaThe American Journal of Tropical Medicine and Hygiene, 1990